| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.004 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.004 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.006 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.17 | 0.008 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.008 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.008 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |